Article

Antibacterial treatment strategies in hospitalized patients: What role for pharmacoeconomics?

Author and Disclosure Information

ABSTRACT

Antimicrobial agents continue to account for a significant portion of institutional pharmaceutical expenditures. Pharmacoeconomic analysis is a valuable tool in assessing antibacterial agents for their place in institutional formularies. This article reviews various types of pharmacoeconomic analyses, their respective limitations, and their roles in the antibacterial formulary decision-making process. We also discuss the current state of the antibacterial pharmacoeconomic literature, including the economic impact of antimicrobial resistance.


 

Next Article:

Colorectal cancer screening lacks evidence of benefit

Related Articles